Literature DB >> 26760137

Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands Study of Depression and Anxiety.

Deborah Gibson-Smith1, Mariska Bot, Yuri Milaneschi, Jos W Twisk, Marjolein Visser, Ingeborg A Brouwer, Brenda W J H Penninx.   

Abstract

BACKGROUND: Although depression and obesity are bidirectionally associated, little is known about weight changes following major depressive disorder (MDD). This study compared 2-year weight changes between patients with current MDD (cMDD), patients with remitted MDD (rMDD), and healthy controls. Additionally, we examined the relationship between antidepressant medication use and 2-year weight change.
METHOD: Data from 2,542 adults aged 18-65 y were sourced from the Netherlands Study of Depression and Anxiety. Data were collected at baseline and after 2, 4, and 6 years (September 2004-April 2013). Depression status (DSM-IV criteria for MDD) was established with the Composite International Diagnostic Interview. Subsequent 2-year weight changes were categorized as weight loss (> 5% loss), weight stable (within 5% weight loss or gain), and weight gain (> 5% gain). The association of depression status with subsequent weight change, with weight stable as reference category, was studied by combining all repeated measurements in a mixed multinomial logistical regression model.
RESULTS: cMDD, but not rMDD, was significantly associated with both weight gain and weight loss over a 2-year period after adjustment for covariates (odds ratio [OR] = 1.67; 95% confidence interval [CI], 1.37-2.03; P < .001; and OR = 1.27; 95% CI 1.01-1.61; P = .045, respectively). Antidepressant use was associated with weight gain (SSRIs: OR = 1.26; 95% CI, 1.05-1.52; other antidepressants: OR = 1.36; 95% CI, 1.00-1.84; P < .05 for both), but not after considering depression status. Compared to cMDD patients who lost weight, those who gained weight had lower initial weight, were younger, had more comorbid anxiety disorders, and reported poorer quality of mood and reduced appetite as depressive symptoms.
CONCLUSIONS: Compared to controls, cMDD participants have greater odds of either gaining or losing weight over a 2-year period, regardless of antidepressant use. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26760137     DOI: 10.4088/JCP.14m09658

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

Review 1.  Association of first-line antidepressants and incident adverse metabolic effects.

Authors:  Frances K Wen; Kimberly Crosby; Barbara H Miller; Michael Rommen; Samuel J Kirzner; Toni Hoberecht; Alyssa Migdalski
Journal:  Can Fam Physician       Date:  2020-12       Impact factor: 3.275

2.  Who should be "controls" in studies on the neurobiology of psychiatric disorders?

Authors:  Patricia Boksa; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2018-08       Impact factor: 6.186

3.  Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors.

Authors:  Chadi A Calarge; James A Mills; Kathleen F Janz; Trudy L Burns; William H Coryell; Babette S Zemel
Journal:  Pediatrics       Date:  2017-06-16       Impact factor: 7.124

4.  Polygenic dissection of major depression clinical heterogeneity.

Authors:  Y Milaneschi; F Lamers; W J Peyrot; A Abdellaoui; G Willemsen; J-J Hottenga; R Jansen; H Mbarek; A Dehghan; C Lu; D I Boomsma; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2015-06-30       Impact factor: 15.992

5.  Pre- and Early Pregnancy Onset Depression and Subsequent Rate of Gestational Weight Gain.

Authors:  Sylvia E Badon; Monique M Hedderson; Rebecca J Hyde; Charles P Quesenberry; Lyndsay A Avalos
Journal:  J Womens Health (Larchmt)       Date:  2019-05-07       Impact factor: 2.681

6.  Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women.

Authors:  Kristine M Erlandson; Long Zhang; Jordan E Lake; Jennifer Schrack; Keri Althoff; Anjali Sharma; Phyllis C Tien; Joseph B Margolick; Lisa P Jacobson; Todd T Brown
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Depression and anxiety behaviour in a rat model of chronic migraine.

Authors:  Mingjie Zhang; Yufei Liu; Mangsuo Zhao; Wenjing Tang; Xiaolin Wang; Zhao Dong; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-02-21       Impact factor: 7.277

8.  SSRI antidepressant use potentiates weight gain in the context of unhealthy lifestyles: results from a 4-year Australian follow-up study.

Authors:  Zumin Shi; Evan Atlantis; Anne W Taylor; Tiffany K Gill; Kay Price; Sarah Appleton; Ma-Li Wong; Julio Licinio
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

9.  Depression and obesity, data from a national administrative database study: Geographic evidence for an epidemiological overlap.

Authors:  Jean-Christophe Chauvet-Gelinier; Adrien Roussot; Jonathan Cottenet; Marie-Claude Brindisi; Jean-Michel Petit; Bernard Bonin; Bruno Vergès; Catherine Quantin
Journal:  PLoS One       Date:  2019-01-08       Impact factor: 3.240

Review 10.  Depression and obesity: evidence of shared biological mechanisms.

Authors:  Yuri Milaneschi; W Kyle Simmons; Elisabeth F C van Rossum; Brenda Wjh Penninx
Journal:  Mol Psychiatry       Date:  2018-02-16       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.